June 2020
Key Points The risk of cancer from taking NDMA contaminated products is low. Patients should continue taking metformin, even if affected by the recall, until they have a replacement or different treatment option from their doctor or pharmacist. Metformin Recall In late 2019, the Federal Drug Administration (FDA) announced that there had been findings of...
Read More
Key Points Many payers use CMS Performance Measures and STAR ratings to provide incentives to increase quality of care. Medication adherence is one of the performance measures that is monitored. Implementation of this initiative will increase quality of care with the additional bonus of increasing our performance measures and STAR ratings. A new Medication Adherence...
Read More
Keep updated on COVID-19 by entering our secure Member's Portal.ENTER HERE >